RVNC - Revance Therapeutics Inc. (RVNC) CEO Mark Foley on Q3 2020 Results - Earnings Call Transcript
Revance Therapeutics, Inc. (RVNC) Q3 2020 Earnings Conference Call November 09, 2020 4:30 PM ET Company Participants Jeanie Herbert - Head of Investor Relations Mark Foley - President & Chief Executive Officer Toby Schilke - Chief Financial Officer Dustin Sjuts - Chief Commercial Officer, Therapeutics & Aesthetics Conference Call Participants Ken Cacciatore - Cowen & Company Annabel Samimy - Stifel Terence Flynn - Goldman Sachs David Amsellem - Piper Sandler Kush Patel - Guggenheim Tim Lugo - William Blair Serge Belanger - Needham & Company Balaji Prasad - Barclays Chris Bialas - H.C. Wainwright Presentation Operator Welcome to the Revance Therapeutics Third Quarter 2020 Financial Results and Corporate Update Conference Call. At this time, all participants are in a listen-only mode. Following managements' prepared remarks, we will hold a Q&A session. [Operator Instructions] As a reminder, today's call is being recorded today, November 9, 2020. I would now like to
For further details see:
Revance Therapeutics, Inc. (RVNC) CEO Mark Foley on Q3 2020 Results - Earnings Call Transcript